Latest Market News

HITIQ Limited is set to debut its PROTEQT concussion management system in the UK on August 4, 2025, uniquely integrating with NHS 111 telehealth services to offer free medical guidance. This launch marks HITIQ’s first international consumer market entry and a strategic step in its global expansion.

Environmental Clean Technologies Limited (ECT) plans a 15-to-1 capital consolidation to streamline its share structure and attract broader investor interest, pending shareholder approval in August 2025.

Almonty Industries has had its trading suspension lifted following the release of an updated technical report on its Sangdong Project in South Korea, signaling renewed investor access and potential project reassessment.

Almonty Industries has released an updated JORC technical report for its Sangdong Tungsten Mine, affirming Phase I production commencement in late 2025 and outlining plans for a fully permitted Phase II expansion to double throughput.

RBR Group Limited has launched a Share Purchase Plan to raise up to $650,000, offering eligible shareholders shares at a notably low price of $0.001 each. The funds will support a joint venture, repay convertible notes, and bolster working capital.

Castile Resources has integrated bismuth as a by-product into its Rover 1 Bankable Feasibility Study following China’s export restrictions, positioning itself as a key supplier amid global supply shocks. The company also advances exploration with innovative technology and secures strategic partnerships in critical mineral supply chains.

Bryah Resources has exercised its option to acquire the Golden Pike gold and antimony project in New Brunswick, Canada, aiming to add significant value with a high-grade resource. The acquisition follows thorough due diligence and complements Bryah’s existing Australian portfolio.

Invion Limited’s IVXO securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing and investor confidence.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Spartan Resources held a pivotal Scheme Meeting to decide on Ramelius Resources' proposed acquisition, with the board unanimously backing the deal. The transaction offers Spartan shareholders a mix of cash and Ramelius shares, pending court approval.

Argosy Minerals has reached a key agreement to develop a 40MW energy infrastructure for its Rincon Lithium Project in Argentina, paving the way for expanded lithium production and enhanced project viability.

Pharmx Technologies has extended its pivotal National Diabetes Services Scheme agreement and expanded its supplier base, reinforcing its leadership in pharmacy digital infrastructure across Australia and New Zealand.